Morgan Stanley’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.8M Sell
245,859
-23,245
-9% -$252K ﹤0.01% 4517
2025
Q4
$3.46M Buy
269,104
+30,325
+13% +$374K ﹤0.01% 4446
2025
Q3
$2.67M Sell
238,779
-45,497
-16% -$439K ﹤0.01% 4601
2025
Q2
$2.82M Sell
284,276
-419,209
-60% -$4.1M ﹤0.01% 4488
2025
Q1
$6.61M Buy
703,485
+176,328
+33% +$1.85M ﹤0.01% 3688
2024
Q4
$4.83M Sell
527,157
-85,043
-14% -$625K ﹤0.01% 4032
2024
Q3
$4.76M Sell
612,200
-473,448
-44% -$3.42M ﹤0.01% 3991
2024
Q2
$6.57M Sell
1,085,648
-791,000
-42% -$4.88M ﹤0.01% 3671
2024
Q1
$11M Sell
1,876,648
-1,895,752
-50% -$11.3M ﹤0.01% 3277
2023
Q4
$29.6M Buy
3,772,400
+2,221,410
+143% +$15.4M ﹤0.01% 2987
2023
Q3
$11.3M Buy
1,550,990
+1,017,584
+191% +$8.47M ﹤0.01% 3008
2023
Q2
$5.56M Buy
533,406
+156,859
+42% +$1.51M ﹤0.01% 3691
2023
Q1
$3.89M Buy
376,547
+3,070
+0.8% +$39.3K ﹤0.01% 3979
2022
Q4
$5.14M Buy
373,477
+90,798
+32% +$1.26M ﹤0.01% 3738
2022
Q3
$5.78M Buy
282,679
+17,647
+7% +$387K ﹤0.01% 3550
2022
Q2
$5.13M Buy
265,032
+74,137
+39% +$1.52M ﹤0.01% 3735
2022
Q1
$4.11M Sell
190,895
-78,904
-29% -$1.79M ﹤0.01% 3901
2021
Q4
$7.44M Sell
269,799
-28,019
-9% -$773K ﹤0.01% 3290
2021
Q3
$7.73M Buy
297,818
+8,362
+3% +$224K ﹤0.01% 3215
2021
Q2
$7.85M Buy
289,456
+135,460
+88% +$3.31M ﹤0.01% 3276
2021
Q1
$3.6M Sell
153,996
-207,265
-57% -$4.19M ﹤0.01% 3748
2020
Q4
$5.54M Buy
361,261
+196,655
+119% +$2.5M ﹤0.01% 3152
2020
Q3
$1.99M Buy
164,606
+49,200
+43% +$467K ﹤0.01% 3665
2020
Q2
$1.17M Sell
115,406
-285
-0.2% -$2.94K ﹤0.01% 4050
2020
Q1
$1.21M Sell
115,691
-180,099
-61% -$2.26M ﹤0.01% 3804
2019
Q4
$4.74M Buy
295,790
+67,549
+30% +$1.03M ﹤0.01% 3261
2019
Q3
$4.21M Buy
228,241
+61,021
+36% +$1.19M ﹤0.01% 3056
2019
Q2
$3.29M Buy
167,220
+33,550
+25% +$683K ﹤0.01% 3340
2019
Q1
$3.06M Sell
133,670
-58,647
-30% -$1.27M ﹤0.01% 3197
2018
Q4
$3.87M Buy
192,317
+16,524
+9% +$342K ﹤0.01% 3189
2018
Q3
$3.82M Sell
175,793
-31,583
-15% -$701K ﹤0.01% 3465
2018
Q2
$4.61M Buy
207,376
+31,315
+18% +$640K ﹤0.01% 3232
2018
Q1
$3.04M Buy
176,061
+42,913
+32% +$716K ﹤0.01% 3589
2017
Q4
$2.21M Buy
133,148
+67,289
+102% +$1.15M ﹤0.01% 3946
2017
Q3
$1.13M Sell
65,859
-28,340
-30% -$476K ﹤0.01% 4341
2017
Q2
$1.53M Sell
94,199
-146,574
-61% -$2.32M ﹤0.01% 4033
2017
Q1
$4.18M Buy
240,773
+4,669
+2% +$78.1K ﹤0.01% 3046
2016
Q4
$3.98M Buy
236,104
+173,778
+279% +$2.9M ﹤0.01% 3238
2016
Q3
$1.09M Buy
62,326
+2,350
+4% +$38.1K ﹤0.01% 3965
2016
Q2
$862K Sell
59,976
-35,501
-37% -$444K ﹤0.01% 4085
2016
Q1
$1.17M Sell
95,477
-3,157
-3% -$34.9K ﹤0.01% 3808
2015
Q4
$1.2M Buy
98,634
+5,728
+6% +$70.5K ﹤0.01% 3925
2015
Q3
$1.23M Buy
92,906
+76,683
+473% +$1.16M ﹤0.01% 3947
2015
Q2
$266K Sell
16,223
-31,419
-66% -$522K ﹤0.01% 5107
2015
Q1
$847K Buy
47,642
+40,348
+553% +$750K ﹤0.01% 4253
2014
Q4
$139K Buy
7,294
+2,081
+40% +$35.3K ﹤0.01% 5409
2014
Q3
$71K Sell
5,213
-26,107
-83% -$373K ﹤0.01% 5607
2014
Q2
$513K Sell
31,320
-11,265
-26% -$163K ﹤0.01% 4552
2014
Q1
$671K Buy
42,585
+452
+1% +$7.36K ﹤0.01% 4341
2013
Q4
$723K Buy
42,133
+6,134
+17% +$94.4K ﹤0.01% 4190
2013
Q3
$476K Buy
+35,999
New +$424K ﹤0.01% 4367

Other funds holding ANGO

Morgan Stanley's ANGO Position: Q1 2026 in Review

Morgan Stanley reduced its AngioDynamics (ANGO) stake by 8.6% in Q1 2026, selling an estimated $252K and leaving 245,859 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #4517.

Morgan Stanley first reported a position in ANGO in Q3 2013 and has held it in 51 quarters since. The position peaked at $29.6M in Q4 2023. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Morgan Stanley held 245,859 shares of AngioDynamics worth $2.8M as of Q1 2026.
  • Morgan Stanley sold 23,245 AngioDynamics shares in Q1 2026, an estimated $252K.
  • AngioDynamics made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4517 holding.
  • Morgan Stanley first reported a position in AngioDynamics in Q3 2013 and has held it in 51 quarters since.
  • Morgan Stanley's AngioDynamics position peaked at $29.6M in Q4 2023.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.